These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 33715271)

  • 1. Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.
    Chebly A; Ropio J; Peloponese JM; Poglio S; Prochazkova-Carlotti M; Cherrier F; Ferrer J; Idrissi Y; Segal-Bendirdjian E; Chouery E; Farra C; Pham-Ledard A; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
    Mol Oncol; 2022 May; 16(9):1931-1946. PubMed ID: 33715271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.
    Chebly A; Prochazkova-Carlotti M; Idrissi Y; Bresson-Bepoldin L; Poglio S; Farra C; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
    Front Oncol; 2021; 11():775253. PubMed ID: 34765562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
    Apolónio JD; Dias JS; Fernandes MT; Komosa M; Lipman T; Zhang CH; Leão R; Lee D; Nunes NM; Maia AT; Morera JL; Vicioso L; Tabori U; Castelo-Branco P
    Clin Epigenetics; 2022 Dec; 14(1):178. PubMed ID: 36529814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.
    Garsuault D; Bouyer C; Nguyen E; Kandhari R; Prochazkova-Carlotti M; Chevret E; Forgez P; Ségal-Bendirdjian E
    Mol Oncol; 2020 Jun; 14(6):1310-1326. PubMed ID: 32239597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on
    Ropio J; Prochazkova-Carlotti M; Batista R; Pestana A; Chebly A; Ferrer J; Idrissi Y; Cappellen D; Durães C; Boaventura P; Vinagre J; Azzi-Martin L; Poglio S; Cabeçadas J; Campos MA; Beylot-Barry M; Sobrinho-Simões M; Merlio JP; Soares P; Chevret E
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
    Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC
    Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
    Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
    Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
    Rozati S; Cheng PF; Widmer DS; Fujii K; Levesque MP; Dummer R
    Clin Cancer Res; 2016 Apr; 22(8):2020-31. PubMed ID: 26660520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
    Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
    J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
    Li CT; Hsiao YM; Wu TC; Lin YW; Yeh KT; Ko JL
    J Cell Biochem; 2011 Oct; 112(10):3044-53. PubMed ID: 21678477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
    Bechter OE; Eisterer W; Dlaska M; Kühr T; Thaler J
    Exp Hematol; 2002 Jan; 30(1):26-33. PubMed ID: 11823034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between CpG island methylation of hTERT promoter and human age prediction.
    Cui H; Xin Y; Cao F; Gan Z; Tian Y; Liu W; Shi P
    Leg Med (Tokyo); 2023 Jul; 63():102270. PubMed ID: 37207612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
    Guilleret I; Benhattar J
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
    Azouz A; Wu YL; Hillion J; Tarkanyi I; Karniguian A; Aradi J; Lanotte M; Chen GQ; Chehna M; Ségal-Bendirdjian E
    Leukemia; 2010 Mar; 24(3):613-22. PubMed ID: 20072159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.
    Rowland TJ; Bonham AJ; Cech TR
    Mol Oncol; 2020 Oct; 14(10):2358-2374. PubMed ID: 33245585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
    Choi JH; Park SH; Park J; Park BG; Cha SJ; Kong KH; Lee KH; Park AJ
    Biochem Biophys Res Commun; 2007 Sep; 361(3):615-20. PubMed ID: 17673177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential DNA Methylation of THOR and
    Ott P; Araúzo-Bravo MJ; Hoffmann MJ; Poyet C; Bendhack ML; Santourlidis S; Erichsen L
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells.
    Lopatina NG; Poole JC; Saldanha SN; Hansen NJ; Key JS; Pita MA; Andrews LG; Tollefsbol TO
    Biochem Biophys Res Commun; 2003 Jul; 306(3):650-9. PubMed ID: 12810068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
    de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
    BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.